Chandra Bhagat Pharma Limited (CBPL.BO)
INR 65.0
(0.0%)
INR 65.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 15.3 Million INR | 69.02% |
| 2022 | 9.05 Million INR | 13.64% |
| 2021 | 7.96 Million INR | 319.54% |
| 2020 | 1.89 Million INR | -39.67% |
| 2019 | 3.14 Million INR | -54.29% |
| 2018 | 6.88 Million INR | -33.39% |
| 2017 | 10.33 Million INR | 56.57% |
| 2016 | 6.6 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | 3.17 Million INR | 0.0% |
| 2023 Q1 | 2.68 Million INR | 0.0% |
| 2023 Q2 | 3.17 Million INR | 18.27% |
| 2022 FY | 9.05 Million INR | 13.64% |
| 2022 Q2 | 1.84 Million INR | 1.15% |
| 2022 Q4 | 2.68 Million INR | 45.63% |
| 2022 Q1 | 1.82 Million INR | 0.0% |
| 2022 Q3 | 1.84 Million INR | 0.0% |
| 2021 Q3 | 2.16 Million INR | 0.0% |
| 2021 Q4 | 1.82 Million INR | -15.7% |
| 2021 FY | 7.96 Million INR | 319.54% |
| 2021 Q1 | 776.99 Thousand INR | 0.0% |
| 2021 Q2 | 2.16 Million INR | 178.16% |
| 2020 Q2 | 172.5 Thousand INR | -87.69% |
| 2020 FY | 1.89 Million INR | -39.67% |
| 2020 Q1 | 1.4 Million INR | 0.0% |
| 2020 Q3 | 172.5 Thousand INR | 0.0% |
| 2020 Q4 | 776.99 Thousand INR | 350.41% |
| 2019 Q2 | 172.5 Thousand INR | 0.0% |
| 2019 FY | 3.14 Million INR | -54.29% |
| 2019 Q4 | 1.4 Million INR | 712.33% |
| 2019 Q3 | 172.5 Thousand INR | 0.0% |
| 2018 FY | 6.88 Million INR | -33.39% |
| 2017 FY | 10.33 Million INR | 56.57% |
| 2016 FY | 6.6 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Checkpoint Trends Limited | 302.09 Thousand INR | -4965.709% |
| Everest Organics Limited | 1.39 Million INR | -999.353% |
| GUJARAT INJECT (KERALA) LTD. | 827.62 Thousand INR | -1749.017% |
| NATURO INDIABULL LIMITED | 9.93 Million INR | -54.093% |
| NEXUS SURGICAL AND MEDICARE LI | 2.13 Million INR | -617.412% |
| Rajnish Wellness Limited | 10.33 Million INR | -48.113% |
| Rama Vision Limited | 33.85 Million INR | 54.801% |
| Vivo Bio Tech Limited | 25.26 Million INR | 39.425% |